Skip to main content

Table 1 Outcome measures

From: Light therapy for better mood and insulin sensitivity in patients with major depression and type 2 diabetes: a randomised, double-blind, parallel-arm trial

Weeks relative to start intervention (T)

 

0

1

2

3

4

5

6

7

8

Visits

S

1

   

2

   

3

Telephone contact

  

1

2

3

  

4

  

Run-in phase

X-es

X-es

        

Intervention phase

  

X-es

X-es

X-es

X-es

    

Follow-up phase

      

X-es

X-es

X-es

X-es

Participant characteristics

Psychiatric diagnosis, seasonality, chronotype, sleep apnoea, medical history, current medication, biochemical blood tests, sociodemographic factors

X

X

        

Psychometrical measures

Depressive symptoms

 

X

X

X

X

X

   

X

Anxiety symptoms

 

X

X

X

X

X

   

X

Diabetes-related distress

 

X

   

X

   

X

Quality of life, disability

 

X

   

X

   

X

Glucometabolic measures

Insulin sensitivity

 

X

   

X

    

HbA1c level

 

X

   

X

   

X

Fasting glucose level

 

X

   

X

   

X

Hypoglycaemic events

 

X

X

X

X

X

   

X

Circadian mediating factors

Diurnal HPA axis activity

 

X

   

X

   

X

Objective sleep

 

X

   

X

   

X

Subjective sleep

 

X

X

X

X

X

   

X

Other factors

Body weight, body mass index, waist-hip ratio, body composition

 

X

   

X

   

X

Physical activity

 

X

   

X

   

X

Autonomic nervous system function

 

X

   

X

   

X

Safety

Adverse effects

 

X

X

X

X

X

   

X

Ophthalmological examination

X

        

X

Compliance

Participant-report compliance

  

X

X

X

X

    

Light meter

 

X

   

X

   

X

  1. Abbreviations: S screening, HPA hypothalamic-pituitary-adrenal